Enquiry/Quote

How to Source PIRFENIDONE Capsule for Pharmaceutical Formulation

PIRFENIDONE Capsule (Capsules, 267 mg) is classified under Respiratory Disorder. It is therapeutically aligned with reference brands such as Esbriet (USA/EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality PIRFENIDONE Capsule for formulation, R&D, or bulk manufacturing.

Product Overview: Tablet contains pirfenidone. It is used to treat idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a type of lung disorder in which tissues of the lungs become scarred and inflamed, resulting in breathing difficulties. This medicine should not be used if you have severe liver disorders, severe kidney disorders, if you are taking fluvoxamine (treats depression and obsessive compulsive disorder), or if you are allergic to any of the ingredients of this medicine. This medicine is not recommended for adolescents and children under the age of 18. Avoid smoking as...

PIRFENIDONE Capsule API in Capsules form, 267 mg specification
PIRFENIDONE Capsule API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

PIRFENIDONE Capsule must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for PIRFENIDONE Capsule is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing PIRFENIDONE Capsule is more than procurement—it’s a strategic partnership. With its capsules form and 267 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing PIRFENIDONE Capsule.

Request a Quote

Frequently Asked Questions For Sourcing of PIRFENIDONE Capsule

What is the typical lead time for PIRFENIDONE Capsule?

Lead times range from 4–6 weeks depending on supplier and region.

Is PIRFENIDONE Capsule available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does PIRFENIDONE Capsule require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for PIRFENIDONE Capsule?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of PIRFENIDONE Capsule?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for PIRFENIDONE Capsule?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is PIRFENIDONE Capsule suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can PIRFENIDONE Capsule be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.